Aspirin

Description

The drug is identified by SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, which is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the temporary relief of pain and fever associated with colds, as well as for the alleviation of headache, muscle pain, minor pain of arthritis, toothache, and menstrual pain.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

Patients should take each dose with a full glass of water to ensure proper administration.

For adults and children aged 12 years and older, the recommended dosage is either 1 or 2 tablets every 4 hours, or 3 tablets every 6 hours. The total daily dosage must not exceed 12 tablets within a 24-hour period unless otherwise directed by a healthcare professional.

For children under 12 years of age, the use of this medication is not recommended unless specifically directed by a physician.

Contraindications

Use of this product is contraindicated in individuals with a known allergy to aspirin or any other pain reliever or fever reducer. Additionally, it should not be used in patients who have a history of allergic reactions to this product or any of its components.

Warnings and Precautions

Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product due to the risk of Reye's syndrome, a rare but serious illness. If changes in behavior accompanied by nausea and vomiting occur while using this product, it is imperative to consult a healthcare professional, as these symptoms may indicate the onset of Reye's syndrome.

Aspirin may provoke severe allergic reactions, which can manifest as facial swelling, shock, hives, or asthma symptoms such as wheezing. Healthcare professionals should be vigilant for these signs and advise patients to seek immediate medical attention if they occur.

This product contains a nonsteroidal anti-inflammatory drug (NSAID), which carries a risk of severe stomach bleeding. The likelihood of this adverse effect increases in patients who are 60 years of age or older, those taking other NSAIDs (including prescription and nonprescription medications such as aspirin, ibuprofen, or naproxen), individuals consuming three or more alcoholic drinks daily while using this product, and patients who exceed the recommended dosage or duration of use. Additionally, those with a history of stomach ulcers or bleeding problems, or who are on anticoagulant or steroid medications, should exercise caution.

Before initiating treatment, patients should consult a healthcare provider if they have asthma, a history of stomach issues (such as heartburn), high blood pressure, heart disease, liver cirrhosis, or kidney disease. It is also advisable to seek guidance from a doctor or pharmacist if the patient is currently taking prescription medications for gout, diabetes, or arthritis.

In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Patients are advised to discontinue use and contact a healthcare professional if any of the following occur: signs of an allergic reaction; symptoms indicative of stomach bleeding, such as bloody or black stools, faintness, persistent stomach pain, or vomiting blood; tinnitus or hearing loss; worsening pain lasting more than 10 days; fever that worsens or persists beyond three days; visible redness or swelling; or the emergence of new symptoms. These may signify a serious condition requiring prompt medical evaluation.

Side Effects

Patients using this product should be aware of several serious adverse reactions associated with its use. Reye's syndrome is a rare but serious illness that may occur in children and teenagers who have or are recovering from chickenpox or flu-like symptoms. If patients experience changes in behavior accompanied by nausea and vomiting while using this product, they should consult a doctor immediately, as these symptoms could indicate the onset of Reye's syndrome.

Additionally, there is a significant risk of severe allergic reactions to aspirin, which may manifest as facial swelling, shock, hives, or asthma (wheezing). Patients experiencing any signs of an allergic reaction should seek medical attention promptly.

This product contains a nonsteroidal anti-inflammatory drug (NSAID), which may lead to severe stomach bleeding. The risk of this adverse reaction is heightened in patients who are 60 years of age or older, those taking other NSAIDs (either prescription or nonprescription), individuals consuming three or more alcoholic drinks daily while using this product, and patients with a history of stomach ulcers or bleeding problems. Furthermore, prolonged use or exceeding the recommended dosage, as well as concurrent use of blood thinners or steroid medications, may increase the likelihood of stomach bleeding.

Patients are advised to discontinue use and consult a doctor if they experience any signs of an allergic reaction or symptoms indicative of stomach bleeding, such as bloody or black stools, faintness, persistent stomach pain, or vomiting blood. Other concerning symptoms that warrant medical attention include ringing in the ears or loss of hearing, worsening pain lasting more than 10 days, fever persisting beyond three days, redness or swelling, or the emergence of new symptoms. These could signify a serious condition requiring immediate evaluation.

Drug Interactions

Concurrent use of nonsteroidal anti-inflammatory drugs (NSAIDs), including both prescription and nonprescription agents such as aspirin, ibuprofen, and naproxen, may elevate the risk of severe gastrointestinal bleeding. Caution is advised when these medications are used in combination.

The concomitant administration of anticoagulants or steroid medications may similarly increase the risk of severe stomach bleeding. Healthcare providers should evaluate the necessity of dosage adjustments or enhanced monitoring for patients receiving these combinations.

Patients are advised to consult with a healthcare professional prior to using this medication if they are currently prescribed drugs for gout, diabetes, or arthritis to ensure safe and effective use.

No specific interactions with laboratory tests have been identified in the available data.

Packaging & NDC

Below are the non-prescription pack sizes of Aspirin. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product due to the risk of Reye's syndrome, a rare but serious illness. If pediatric patients experience changes in behavior accompanied by nausea and vomiting while using this product, a healthcare professional should be consulted, as these symptoms may indicate the onset of Reye's syndrome.

For children under 12 years of age, the product should not be used unless directed by a doctor. In contrast, for adolescents and adults aged 12 years and older, the recommended dosage is 1 or 2 tablets every 4 hours or 3 tablets every 6 hours, with a maximum of 12 tablets in a 24-hour period unless otherwise directed by a healthcare professional.

Geriatric Use

Elderly patients, particularly those aged 60 and older, are at an increased risk for severe stomach bleeding. This heightened risk necessitates careful consideration and monitoring when prescribing medications that may contribute to gastrointestinal complications.

Healthcare providers should advise geriatric patients to consult with their physician if they have a history of stomach issues, such as heartburn, or if they fall within the age group where the stomach bleeding warning is applicable. It is essential to evaluate the patient's overall health status and any potential contraindications before initiating treatment, ensuring that appropriate precautions are taken to mitigate risks associated with gastrointestinal bleeding.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to use. The use of aspirin during the last trimester of pregnancy is particularly cautioned against, as it may lead to adverse effects on fetal outcomes or complications during delivery. Therefore, it is essential that pregnant patients only use aspirin in this period if explicitly directed by a healthcare provider.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication if they are pregnant or breastfeeding. It is particularly important to avoid the use of aspirin during the last three months of pregnancy unless specifically directed by a healthcare provider, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants.

Renal Impairment

Patients with renal impairment should consult a healthcare professional prior to use, particularly if they have comorbid conditions such as high blood pressure, heart disease, liver cirrhosis, or kidney disease. It is essential to assess renal function and consider potential dosing adjustments or monitoring requirements based on the degree of renal impairment.

Hepatic Impairment

Patients with hepatic impairment should consult a healthcare professional prior to use, particularly if they have conditions such as liver cirrhosis. It is essential for these patients to receive appropriate evaluation and monitoring of their liver function to ensure safe and effective use of the medication. Adjustments to dosage may be necessary based on the severity of hepatic impairment, and ongoing assessment of liver function is recommended throughout the treatment period.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222. Prompt action is crucial to ensure the safety and well-being of the patient.

Healthcare professionals should be aware that symptoms of overdose may vary depending on the substance involved. Therefore, a thorough assessment of the patient's condition is essential. Monitoring vital signs and conducting appropriate laboratory tests may be necessary to evaluate the extent of the overdose and guide treatment decisions.

Management of an overdose typically involves supportive care, which may include airway management, intravenous fluids, and symptomatic treatment as required. In cases where specific antidotes are available, their administration should be considered based on the clinical scenario.

It is vital for healthcare providers to remain vigilant and prepared to implement emergency protocols in the event of an overdose, ensuring that the patient receives the most effective care possible.

Nonclinical Toxicology

It is especially important not to use aspirin during the last three months of pregnancy unless specifically directed by a healthcare professional, as it may lead to complications for the unborn child or during delivery. No non-teratogenic effects have been provided in the available data. Additionally, there is no information regarding nonclinical toxicology or animal pharmacology and toxicology in the insert.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions reported voluntarily or through surveillance programs.

Allergic reactions have been noted, including facial swelling, shock, hives, and asthma (wheezing). Additionally, cases of stomach bleeding have been reported, particularly in patients who are older, those who take other nonsteroidal anti-inflammatory drugs (NSAIDs), individuals who consume alcohol, or patients with a history of stomach ulcers or bleeding problems.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 in the event of an overdose. It is essential to inform patients that they should not use this product if they have a known allergy to aspirin or any other pain reliever or fever reducer. Additionally, patients should be cautioned against using the product if they have previously experienced an allergic reaction to it or any of its ingredients.

Patients must be instructed to discontinue use and consult a doctor if they experience any signs of an allergic reaction, and to seek medical help immediately in such cases. They should also be made aware of the signs of potential stomach bleeding, which include bloody or black stools, faintness, persistent stomach pain, or vomiting blood, and advised to stop use and contact a healthcare professional if any of these symptoms occur.

Furthermore, patients should be informed to stop use and consult a doctor if they experience ringing in the ears, a loss of hearing, worsening pain that lasts more than 10 days, or a fever that worsens or lasts more than 3 days. They should also be advised to seek medical advice if they notice any redness or swelling or if new symptoms arise, as these may indicate a serious condition.

Healthcare providers should encourage patients to consult a doctor before using the product if they have asthma, a history of stomach problems such as heartburn, or if the warning for stomach bleeding applies to them. Patients with high blood pressure, heart disease, liver cirrhosis, or kidney disease should also be advised to seek medical guidance prior to use. Additionally, those taking a diuretic or prescription medications for gout, diabetes, or arthritis should be encouraged to discuss their current medications with a doctor or pharmacist before using this product.

Storage and Handling

The product is supplied with an expiration date clearly indicated on the package. It should be stored at a controlled room temperature of 25ºC (77ºF). Temporary excursions from this temperature are permissible, provided they remain within the range of 15ºC to 30ºC (59ºF to 86ºF). Proper storage conditions are essential to maintain the integrity and efficacy of the product.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is particularly crucial to avoid aspirin during the last trimester of pregnancy unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery. No further information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Aspirin, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)